Advertisements



Flex Pharma Shares Plunge After Biotech Ends 2 Clinical Trials, Announces 60% Workforce Cut

Flex Pharma Inc (NASDAQ: FLKS) shares are slumping on above-average volume Wednesday following a release from the company announcing the scrapping of two clinical trials and the explo read more.....»»

Category: blogSource: benzingaJun 13th, 2018

Why Gemphire Is Tuesday’s Big Biotech Loser

Gemphire shares were more than halved on Tuesday after the company provided an update in regards to the clinical hold on gemcabene with respect to clinical trials of longer than six months in........»»

Category: blogSource: 247wallstAug 7th, 2018

Flex Pharma Down on Workforce Reduction, Ends Phase II Study

Flex Pharma (FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company also plans to lower its workforce by about 60%. F.....»»

Category: smallbizSource: nytJun 14th, 2018

Flex Pharma to end Phase 2 trials, explore alternatives, cut workforce

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Category: earningsSource: benzinga5 hr. 59 min. ago

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks.....»»

Category: blogSource: benzinga7 hr. 29 min. ago

The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr"s Gene-Edited Therapy, Endra To Offer Shares

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 10) read more.....»»

Category: blogSource: benzingaOct 11th, 2018

Cocrystal Pharma announces clinical trial agreement for CC-31244

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

The Daily Biotech Pulse: TransEnterix"s Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 1) read more.....»»

Category: blogSource: benzingaOct 2nd, 2018

Pfizer Announces Big Changes at the Top

Pfizer shares hit multiyear highs and nearly an all-time in Monday’s session after the pharma giant announced a succession plan for its CEO......»»

Category: blogSource: 247wallstOct 1st, 2018

How the latest Bay Area biotech IPO targets faster, better drug development

With drug development typically taking a dozen years and more than $1 billion, according to some estimates, Sutro Biopharma Inc. had a compelling story to sell investors on its initial public offering: Our technology gets drugs into clinical trials .....»»

Category: topSource: bizjournalsSep 27th, 2018

Geron Plunges 68% After J&J Ends Partnership That Had Ignited Stock

A stellar year for Geron Corp. investors went up in smoke Thursday as shares plummeted on news that Johnson & Johnson will end a licensing partnership and return rights to the biotech company’s sole product candidate......»»

Category: topSource: moneycentralSep 27th, 2018

Shares of biotech firm Geron fall 70% after Johnson & Johnson ends collaboration - CNBC

CNBCShares of biotech firm Geron fall 70% after Johnson & Johnson ends collaborationCNBCShares of biot.....»»

Category: topSource: googlenewsSep 27th, 2018

Kodiak Sciences Announces Potential Pricing for IPO

Clinical-stage biopharmaceutical company Kodiak Sciences expects to price 9 million shares for an initial public company valued up to more than $155 million......»»

Category: blogSource: 247wallstSep 24th, 2018

ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) 

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsSep 17th, 2018

Why Arrowhead Pharma Shares Are Booming

Arrowhead Pharmaceuticals shares made a considerable gain early on Thursday after the firm announced data from its hepatitis B clinical trial with ARO-HBV......»»

Category: blogSource: 247wallstSep 6th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»

Category: earningsSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech .....»»

Category: blogSource: benzingaSep 2nd, 2018

Scholar Rock stock tumbles 11% as Pfizer discontinues similar medication

Scholar Rock Holding Corp. shares dropped 11% in active Thursday trade after Pfizer Inc. announced it plans to stop two ongoing clinical trials for a similar rare-disease drug. The Pfizer drug in question, domagrozumab, w.....»»

Category: topSource: marketwatchAug 30th, 2018

Onconova announces plan for expanding rigosertib clinical trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 21st, 2018

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Category: earningsSource: benzingaAug 17th, 2018